People | March 14, 2023
Precision appoints John Hubbard, PhD, as Board of Directors Chair
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Time to combine innovation, access and technology to deliver positive patient outcomes
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
Subscribe To Our Newsletter & Stay Updated
